Published in Inflammopharmacology on June 24, 2013
Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol (2011) 4.67
Biphasic development of carrageenin edema in rats. J Pharmacol Exp Ther (1969) 4.24
Carrageenan-induced paw edema in the rat and mouse. Methods Mol Biol (2003) 2.11
Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth (2011) 1.95
Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci (2008) 1.94
Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin (2010) 1.54
Recent advances in the study on capsaicinoids and capsinoids. Eur J Pharmacol (2010) 1.40
Pharmacological analysis of the acute inflammatory process induced in the rat's paw by local injection of carrageenin and by heating. Br J Pharmacol (1973) 1.32
Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides (2004) 1.26
Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol (2003) 1.20
Antioxidant and anti-inflammatory activities of selected medicinal plants containing phenolic and flavonoid compounds. J Agric Food Chem (2011) 1.18
Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages. Cell Signal (2003) 1.13
Topical NSAID therapy for musculoskeletal pain. Pain Med (2010) 1.12
Dietary polyphenols, inflammation, and cancer. Nutr Cancer (2009) 1.02
Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention. Semin Arthritis Rheum (2008) 1.00
Substance P in sensory nerve fibres contributes to the development of oedema in the rat hind paw after thermal injury. Br J Pharmacol (1984) 0.98
Anti-inflammatory effects of red pepper (Capsicum baccatum) on carrageenan- and antigen-induced inflammation. J Pharm Pharmacol (2008) 0.97
Topical therapies for osteoarthritis. Drugs (2011) 0.94
Regulation of inflammatory responses by sensory neurons: molecular mechanism(s) and possible therapeutic applications. Curr Med Chem (2006) 0.92
Effect of curcumin and capsaicin on arachidonic acid metabolism and lysosomal enzyme secretion by rat peritoneal macrophages. Lipids (1997) 0.85
Topical capsaicin. The fire of a 'hot' medicine is reignited. Expert Opin Pharmacother (2010) 0.83
Clinical and experimental aspects of cutaneous neurogenic inflammation. Pharmacol Rep (2006) 0.82
Studies on the metabolism and toxicology of emerging capsinoids. Expert Opin Drug Metab Toxicol (2011) 0.80
Biochemical and molecular analysis of some commercial samples of chilli peppers from Mexico. J Biomed Biotechnol (2012) 0.78
The effect of capsaicin on some experimental inflammations in human skin. Acta Derm Venereol (1986) 0.76
Resveratrol decreases calcium sensitivity of vascular smooth muscle and enhances cytosolic calcium increase in endothelium. Vascul Pharmacol (2006) 0.82
Resveratrol affects histone 3 lysine 27 methylation of vessels and blood biomarkers in DOCA salt-induced hypertension. Mol Biol Rep (2014) 0.78
Assessment of the endothelial functions in monocrotaline-induced pulmonary hypertension. Clin Exp Hypertens (2012) 0.77
Nitric oxide effects depend on different mechanisms in different regions of the rat heart. Heart Vessels (2011) 0.76
Resveratrol-induced depression of the mechanical and electrical activities of the rat heart is reversed by glyburide: evidence for possible K(ATP) channels activation. Arch Pharm Res (2007) 0.75
A case of bladder exstrophy and thoracal intramedullary teratoma. J Pediatr Surg (2004) 0.75